Skip to main content
 

Our Actos News

Several months ago, we brought you a story about a small-town, family-owned drug store in …

In June, the government of India joined those of France and Germany in banning Takeda's flagship diabetic treatment, pioglitazone – better known as Actos, which as been strongly implicated in…

The executives at Takeda Pharmaceuticals may be gloating over their recent victory in which a California judge overturned a $6.5…

Earlier this year, the first of 3000 injury cases against Japanese pharmaceutical company Takeda was heard in a Los Angeles court. The allegation: their flagship product, Actos, had…

News Inferno has reported that another lawsuit against…

Late last month, a Los Angeles jury decided that Takeda executives were in fact aware of the cancer risk from its flagship product, Actos – and ordered the Japanese pharmaceutical giant…

Jack Cooper, a retired communications worker, states that at age sixty-four – prior to being prescribed the diabetic drug Actos – he was in good health and looking forward to many more…

Just two years ago, Takeda Pharmaceuticals' Actos (dabigatran) was the top-selling diabetic drug in the world. With over $4.5 billion in sales, it accounted for 27% of the company's…

Several law firms across the country have issued press releases across the Internet with the news many bladder cancer victims have been waiting for. The first trial involving Takeda…

An example arose in West Virginia recently illustrating how a party other than a drug manufacturer can bear potential liability – in this case, the pharmacy that sold the prescription.

Subscribe to Actos News